Galleri MCED
Selected indexed studies
- Evaluation of cell-free DNA approaches for multi-cancer early detection. (Cancer Cell, 2022) [PMID:36400018]
- Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial. (Cancers (Basel), 2022) [PMID:36230741]
- Promises and pitfalls of multi-cancer early detection using liquid biopsy tests. (Nat Rev Clin Oncol, 2025) [PMID:40514453]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Evaluation of cell-free DNA approaches for multi-cancer early detection. (2022) pubmed
- Multi-cancer early detection tests for general population screening: a systematic literature review. (2025) pubmed
- Cell-Free DNA-Based Multi-Cancer Early Detection Test in an Asymptomatic Screening Population (NHS-Galleri): Design of a Pragmatic, Prospective Randomised Controlled Trial. (2022) pubmed
- Promises and pitfalls of multi-cancer early detection using liquid biopsy tests. (2025) pubmed
- Clinical referral to the NHS following multi-cancer early detection test results from the NHS-Galleri trial. (2025) pubmed
- Real-world data and clinical experience from over 100,000 multi-cancer early detection tests. (2025) pubmed
- Considerations for using potential surrogate endpoints in cancer screening trials. (2024) pubmed
- Impact of Population Cancer Risk on the Cost-effectiveness of Multicancer Early Detection Testing in the United States. (2025) pubmed
- A Cost-Effective Two-Step Approach for Multi-Cancer Early Detection in High-Risk Populations. (2025) pubmed
- Psychological Impact of the Galleri test (sIG(n)al): protocol for a longitudinal evaluation of the psychological impact of receiving a cancer signal in the NHS-Galleri trial. (2023) pubmed